MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-28-0001842
Novel Molecules Private Limited
Novel Molecules Private Limited - chemicals and materials in Khed, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.07 Cr
▼ 46% YoY
Net profit · FY 2025
₹14.6 Lakh
Net margin 13.7%
EBITDA · FY 2025
₹27.02 Lakh
EBITDA margin 25.3%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Open charges
₹29.75 Lakh
Secured borrowings
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
About Novel Molecules Private Limited
Data last updated:
Novel Molecules Private Limited is a private limited company based in Khed, Maharashtra, India. It operates in the industrial chemicals segment of the chemicals and materials sector. It was incorporated on 10 December 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24297PN2019PTC188316. Its GSTIN is 27AAGCN7901E1ZJ (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Sahil Pradeep Mulaokar and Pradeep Digamber Mulaokar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No G – 14 MIDC Lote Parshuram Lote, Khed, Maharashtra, India – 415722.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.07 Cr, a decline of 46% compared to the previous year. For the same year it recorded a net profit of ₹14.6 Lakh (net margin 13.7%) and EBITDA of ₹27.02 Lakh (EBITDA margin 25.3%). Revenue has grown at a compounded annual rate (CAGR) of 38% over three years and 19% over five years.
As per MCA filings, the company has open charges of ₹29.75 Lakh on record.
Novel Molecules Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-28-0001842).
Company details
CIN U24297PN2019PTC188316
Registration Number 188316
Incorporation Date 10 December 2019
ROC Pune
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MH-28-0001842
Recognitions & Rankings of Novel Molecules
Contact details
Novel Molecules Private Limited's registered office is in Khed, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressPlot No G – 14 MIDC Lote Parshuram Lote, Khed, Maharashtra, India – 415722
- IndustryChemicals and Materials, Industrial Chemicals
To see the full contact details of Novel Molecules Private Limited, buy the company report.
Comprehensive company report
Novel Molecules Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Novel Molecules is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Novel Molecules Private Limited, buy the company report.
Financials of Novel Molecules Private Limited
FY 2025 filings availableNovel Molecules Private Limited reported revenue of ₹1.07 Cr (down 46% YoY) for FY 2025.
Revenue · FY 2025
₹1.07 Cr ▼ 46%
Net profit · FY 2025
₹14.6 Lakh margin 13.7%
EBITDA · FY 2025
₹27.02 Lakh margin 25.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 46%
3 years · compounded
▼ 38%
5 years · compounded
▲ 19%
EBITDA CAGR growth
1 year
▼ 34%
3 years · compounded
▼ 12%
5 years · compounded
▲ 70%
Revenue fell 46% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 19%. EBITDA fell 34% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹27.02 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹14.6 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 25.3% | ||||
| Net Profit Margin | 13.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Novel Molecules Private Limited, buy the company report.
Board of directors of Novel Molecules Private Limited
Novel Molecules has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sahil Pradeep Mulaokar Also directs: Beta Molecules LLP, Zephyr Speciality Chemicals Private Limited | Director | 10 Dec 2019 | 6 Years 10 Months | Current |
| Pradeep Digamber Mulaokar | Additional Director | 14 Aug 2021 | 5 Years 2 Months | Current |
Auditor
Novel Molecules Private Limited is audited by SAMIR BHAGAT & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SAMIR BHAGAT & CO | FY 2020 | 136669W |
Shareholding
The shareholding of Novel Molecules Private Limited is on record for FY 2020, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2020 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Novel Molecules Private Limited, buy the company report.
Charges & borrowings
Open charges
₹29.75 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 05 Oct 2021 | 100502702 | Others | ₹18 Lakh | Open | |
| 07 Sep 2021 | 100484026 | Others | ₹11.75 Lakh | Open |
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Novel Molecules Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Novel Molecules Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Novel Molecules has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAGCN7901E1ZJ | Maharashtra | Active | 30 Jan 2020 |
To see the full GST registrations and return filing status of Novel Molecules Private Limited, buy the company report.
Recent activity
Novel Molecules Private Limited has 3 board changes on record since 2019: 2 appointments and 1 cessation. The latest: Pradeep Digamber Mulaokar was appointed as Additional Director on 14 Aug 2021.
AGM
Novel Molecules Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Novel Molecules Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune.
Charges
A charge with Others amounted to Rs. 18.00 Lakh with Charge ID 100502702 was registered on 05 Oct 2021.
Charges
A charge with Others amounted to Rs. 11.75 Lakh with Charge ID 100484026 was registered on 07 Sep 2021.
Appointed
Pradeep Digamber Mulaokar was appointed as Additional Director.
Ceased
Sandesh Jagannath Shinde ceased to be Director.
Appointed
Sahil Pradeep Mulaokar was appointed as Director.
Incorporation
10 Dec 2019
Novel Molecules Private Limited was registered on 10 Dec 2019 with Roc Pune & aged 6 years 10 months as per MCA records.
Frequently asked questions
Novel Molecules is an active private limited company based in Khed, Maharashtra, India. The company works in industrial chemicals, within the chemicals and materials industry. It was incorporated on 10 December 2019 (7+ years old) and is registered under CIN U24297PN2019PTC188316.
Novel Molecules has 2 current directors:
- Sahil Pradeep Mulaokar - Director
- Pradeep Digamber Mulaokar - Additional Director
The latest financial statements of Novel Molecules on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Novel Molecules is 27AAGCN7901E1ZJ, registered in Maharashtra.
The CIN (Corporate Identification Number) of Novel Molecules is U24297PN2019PTC188316. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Novel Molecules was incorporated on 10 December 2019, making it 7+ years old. It is registered with the Registrar of Companies, Pune.
Pradeep Digamber Mulaokar was appointed as Additional Director on 14 Aug 2021. Sandesh Jagannath Shinde ceased to be Director on 14 Aug 2021. Sahil Pradeep Mulaokar was appointed as Director on 10 Dec 2019.
Yes, Novel Molecules is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-28-0001842).
The registered office of Novel Molecules is at Plot No G – 14 MIDC Lote Parshuram Lote, Khed, Maharashtra, India – 415722.
Novel Molecules operates in the chemicals and materials industry, in the industrial chemicals segment.